Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology

ARDX

    • Home
    • ARDX
ARDX Biotechnology Stephen Ayers Uncategorized

Why Ardelyx’s Offensive Strategy Doesn’t Move The Needle

Feb 21, 2026
ARDX Biotechnology Uncategorized

Ardelyx’s post-earnings decline attributed to concerns over Ibsrela outlook

Feb 20, 2026
ARDX Biotechnology Petri Dish Reports Uncategorized

Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability

Feb 20, 2026
ARDX Biotechnology Uncategorized

Ardelyx gains on report Zydus Lifesciences in talks to purchase

Jan 20, 2026
ardelyx-extends-rally-as-piper-sandler-upgrades-on-ibsrela-strength
ARDX Biotechnology Uncategorized

Ardelyx extends rally as Piper Sandler upgrades on Ibsrela strength

Jan 9, 2026

On the Move Comment (1) Pgiam/iStock via Getty Images Ardelyx (ARDX) shares continued to climb...

ARDX Biotechnology Uncategorized

Ardelyx says 2025 total product revenue was about $378M

Jan 8, 2026
ARDX Biotechnology Uncategorized

Ardelyx rises amid report on price hikes for lead product

Jan 2, 2026
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.